Ulrich Mrowietz


Presentations

Insights from the Apremalist After Switching from Fumaric Acid Ester Treatment (APART) Study: An Interim Real-World Safety Analysis 09 October 2019 00:00 - 00:00

Abstracts

Insights from the Apremalist After Switching from Fumaric Acid Ester Treatment (APART) Study: An Interim Real-World Safety Analysis Psoriasis More